Drug Shortage Report for FLOMAX CR
| Report ID | 210443 |
| Drug Identification Number | 02270102 |
| Brand name | FLOMAX CR |
| Common or Proper name | FLOMAX CR |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 3X10 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-11-24 |
| Actual start date | |
| Estimated end date | 2024-02-05 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-11-25 |
| Company comments | Demand increase due to stock out multiple generics. Minimal Available Quantity |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-11-25 | English | Compare |
| v5 | 2023-11-21 | French | Compare |
| v4 | 2023-11-21 | English | Compare |
| v3 | 2023-11-21 | English | Compare |
| v2 | 2023-11-16 | French | Compare |
| v1 | 2023-11-16 | English | Compare |
Showing 1 to 6 of 6